Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements

This document provides guidance on brand name assessment, inner and outer product labels, and risk management planning.

Data and Resources

Additional Info

Field Value
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward